[PLX] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
14-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 155.68%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 65,494 47,638 38,350 62,898 54,693 34,240 19,242 22.63%
PBT 8,566 -14,397 -27,582 -6,523 -18,276 -26,457 -85,276 -
Tax 254 530 6,403 8,369 7,966 536 7,805 -43.48%
NP 8,312 -14,927 -33,985 -14,892 -26,242 -26,457 -85,276 -
Tax Rate -2.97% - - - - - - -
Total Cost 57,182 62,565 72,335 77,790 80,935 60,697 104,518 -9.55%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 12.69 -31.33 -88.62 -23.68 -47.98 -77.27 -443.18 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 0.12 -0.31 -0.77 -0.51 -1.77 -1.80 -6.51 -
EPS Diluted 0.10 -0.31 -0.77 -0.51 -1.77 -1.80 -6.51 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.